TABLE 2 .
Limits of C. albicans-mediated protection
| Primary challenge |
% survival after: |
||
|---|---|---|---|
| C. albicansa | S. aureusb | Primary challengec |
Rechallenge with C. albicans/S. aureus |
| − | − | NA | 25 |
| Live C. albicans | − | 40 (9) | 50 |
| Killed C. albicans | − | 100 | 0 |
| − | Live S. aureus | 100 | 25 |
| − | Killed C. albicans | 100 | 20 |
| Live C. albicans | Killed S. aureus | 60 (5) | 15 |
| Killed C. albicans | Live S. aureus | 100 | 90 |
| Killed C. albicans | Killed S. aureus | 100 | 0 |
a
Inoculum of 1.75 × 107 live or killed C. albicans was injected i.p.
b
Inoculum of 8 × 107 live or killed S. aureus was injected i.p.
c
Results are cumulative from 6 studies with a 14-day observation period. NA, not applicable. Values in parentheses indicate the median time to death of mice that succumbed to infection.